GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 8 filers reported holding GLAXOSMITHKLINE PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $232,000 | +26.8% | 5,494 | +15.4% | 0.00% | +100.0% |
| Q4 2016 | $183,000 | -7.6% | 4,761 | +3.9% | 0.00% | 0.0% |
| Q3 2016 | $198,000 | -0.5% | 4,584 | 0.0% | 0.00% | -50.0% |
| Q2 2016 | $199,000 | +5.9% | 4,584 | -1.1% | 0.00% | +100.0% |
| Q1 2016 | $188,000 | +21.3% | 4,634 | +20.9% | 0.00% | 0.0% |
| Q4 2015 | $155,000 | -89.7% | 3,834 | -90.2% | 0.00% | -91.7% |
| Q3 2015 | $1,501,000 | +0.7% | 39,034 | +9.1% | 0.01% | +9.1% |
| Q2 2015 | $1,491,000 | -7.0% | 35,788 | +3.0% | 0.01% | -8.3% |
| Q1 2015 | $1,604,000 | +247.2% | 34,761 | +221.3% | 0.01% | +300.0% |
| Q4 2014 | $462,000 | +5.7% | 10,820 | +13.8% | 0.00% | 0.0% |
| Q3 2014 | $437,000 | -6.6% | 9,509 | +8.7% | 0.00% | 0.0% |
| Q2 2014 | $468,000 | +31.5% | 8,750 | +31.4% | 0.00% | +50.0% |
| Q1 2014 | $356,000 | +39.1% | 6,658 | +38.7% | 0.00% | 0.0% |
| Q4 2013 | $256,000 | +412.0% | 4,799 | +380.4% | 0.00% | – |
| Q3 2013 | $50,000 | – | 999 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |